Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
y459eFuPjyEUyhrG
Listen
